Novartis' Research Lab Name Change Reflects Strategy Shift
TL;DR Summary
Swiss drugmaker Novartis is changing the name of its research and development hub from Novartis Institutes for BioMedical Research (NIBR) to Novartis BioMedical Research. This name change reflects a shift in the company's research strategy, focusing more on projects likely to yield commercially successful drugs rather than purely scientific discovery.
Topics:health#commercial-success#drug-discovery#novartis#pharmaceuticals#research-and-development#strategy
Reading Insights
Total Reads
0
Unique Readers
91
Time Saved
0 min
vs 1 min read
Condensed
66%
145 → 50 words
Want the full story? Read the original article
Read on STAT